title: Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study.
abstract: OBJECTIVE
  Conventional antipsychotics have been linked to an increased risk of femur fracture. Despite a lower propensity of atypical agents to cause gait and movement disorders, a correlation between these medications and the risk of femur fracture remains to be established. The aim of this study was to estimate the effect of atypical and conventional antipsychotics on the risk of hospitalization for femur fracture.
  
  
  METHODS
  We conducted a case-control study on nursing home residents in 6 U.S. states by using the Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) database, which includes data from the Minimum Data Set linked to Medicare inpatient claims. Cases were residents hospitalized for femur fracture between July 1, 1998, and December 31, 1999. For each case, we identified up to 5 controls residing in the same facility during the same period of time. The sample consisted of 1787 cases and 5606 controls.
  
  
  RESULTS
  After control for potential confounders, the risk of hospitalization for femur fracture was increased for users of atypical (OR = 1.37, 95% confidence interval [CI] = 1.11 to 1.69) and conventional antipsychotics (OR = 1.35, 95% CI = 1.06 to 1.71) relative to nonusers. With respect to individual agents, an excess risk was estimated for risperidone (OR = 1.42, 95% CI = 1.12 to 1.80), olanzapine (OR = 1.34, 95% CI = 0.87 to 2.07), and haloperidol (OR = 1.53, 95% CI = 1.18 to 2.26). No other antipsychotic could be analyzed individually.
  
  
  CONCLUSIONS
  Conventional and atypical antipsychotics appear to increase the risk of hospitalization for femur fracture in a population of institutionalized elderly patients. These medications should be used with caution, especially among patients with a high risk of falls.
authors.affiliation: Center for Medicine of Aging, Department of Gerontology and Geriatrics, Catholic University of the Sacred Heart, Rome, Italy. rossella_liperoti@rm.unicatt.it
authors.forename: Rosa
authors.initials: R
authors.lastname: Liperoti
authors.forename: Graziano
authors.initials: G
authors.lastname: Onder
authors.forename: Kate L
authors.initials: KL
authors.lastname: Lapane
authors.forename: Vincent
authors.initials: V
authors.lastname: Mor
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Friedman
authors.forename: Roberto
authors.initials: R
authors.lastname: Bernabei
authors.forename: Giovanni
authors.initials: G
authors.lastname: Gambassi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D016208:Databases, Factual; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced* / Q000453:epidemiology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D006278:Medicare / Q000706:statistics & numerical data; D009735:Nursing Homes; D016017:Odds Ratio; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D014150:Antipsychotic Agents